Diverticular disease: A therapeutic overview

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 1, Issue 1

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Pharmacology and Therapeutics

ISSN

2150-5349

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Gastrointest Pharmacol Ther. Feb 6, 2010; 1(1): 27-35
Published online Feb 6, 2010. doi: 10.4292/wjgpt.v1.i1.27

Table 3 Current antibiotic therapy in acute diverticulitis

Route	Antibiotic
Oral route	Amoxycillin + clavulanic acid
	Sulphametoxazole-trimethoprim + metronidazole
	Chinolone + metronidazole
Intravenous route	Metronidazole + aminoglycosidic (e.g. gentamicin)
	Clindamycin
	Aztreonam
	Third generation cephalosporins
	Second generation cephalosporins
	Association of severalβ-lactamase inhibitors (e.g.
	ampicillin-sulbactam)

Citation: Tursi A. Diverticular disease: A therapeutic overview. World J Gastrointest Pharmacol Ther 2010; 1(1): 27-35
URL: https://www.wjgnet.com/2150-5349/full/v1/i1/27.htm
DOI: https://dx.doi.org/10.4292/wjgpt.v1.i1.27

Tursi A. Diverticular disease: A therapeutic overview. World J Gastrointest Pharmacol Ther 2010; 1(1): 27-35 [PMID: 21577292 DOI: 10.4292/wjgpt.v1.i1.27]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.